Press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Mar 15, 2010Boston Scientific applies to FDA for expanded indications for TAXUS Express and TAXUS® Liberte® Stents in AMI patients
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of one-year subset data from the HORIZONS AMI trial...
-
Mar 15, 2010
Boston Scientific Corporation (NYSE: BSX) today announced 12-month results from its PERSEUS clinical program that demonstrated...
-
Mar 15, 2010
Boston Scientific Corporation (NYSE: BSX) announced today that it has stopped shipment and is retrieving field inventory of all its implantable...
-
Mar 11, 2010First and only premounted, balloon-expandable stent approved specifically for use in iliac arteries
Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved its Express® LD Iliac...
-
Mar 10, 2010Clinical data presentations to include 12-month results for third-generation TAXUS® Element™ drug-eluting stent
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and news announcements at the 59th Annual...
-
Feb 23, 2010
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the upcoming RBC Capital Markets Health Care Conference in New York City....
-
Feb 10, 2010
Boston Scientific Corporation (NYSE: BSX) today rebutted an article published in the journal HeartRhythm. The article reported a case summary of...
-
Feb 10, 2010New structure, leadership team and targeted portfolio changes will focus on sales excellence and cost effectiveness
Boston Scientific Corporation (NYSE: BSX) today announced a series of management changes and restructuring initiatives designed to strengthen the...
-
Feb 10, 2010
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the fourth quarter and full year ended December 31, 2009, as well...
-
Feb 1, 2010
Boston Scientific Corporation (NYSE: BSX) today announced the settlement of three patent disputes with Johnson & Johnson (J&J). The disputes date...
-
Jan 20, 2010
Boston Scientific Corporation (NYSE: BSX) announced today that the U.S. District Court for the District of Delaware has found all four patents in a...
-
Jan 19, 2010
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the fourth quarter and the year ended...
-
Jan 14, 2010
Boston Scientific Corporation (NYSE: BSX) today announced that the first patient has been enrolled in a clinical trial to...
-
Jan 8, 2010Boston Scientific only company to offer choice of two distinct drugs on separate drug-eluting stent platforms
Boston Scientific Corporation (NYSE: BSX) announced today that it has received approval from the Japanese Ministry of Health, Labor and Welfare...
-
Jan 5, 2010
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the upcoming J.P. Morgan Health Care Conference in San Francisco. Ray...
-
Jan 5, 2010
Boston Scientific Corporation (NYSE: BSX) today announced that it has completed enrollment in its MAPS™ clinical trial, which is studying the...
-
Jan 4, 2010Company to contribute data to industry-sponsored Dual Antiplatelet Therapy (DAPT) Study
Boston Scientific Corporation (NYSE: BSX) today announced that it has enrolled the first patient in its TAXUS Liberte post-approval study. The study...
-
Dec 23, 2009
Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a civil settlement with the U.S. Department of Justice regarding...
-
Dec 16, 2009
Boston Scientific Corporation (NYSE: BSX) today announced that the Company's Board of Directors has elected Nelda Connors as a Director. Ms....
-
Dec 14, 2009
Boston Scientific Corporation (NYSE: BSX) today announced the completion of a public offering of $2 billion aggregate principal amount of its...
-
Dec 10, 2009
Boston Scientific Corporation (NYSE: BSX) today announced the pricing of a public offering of $2 billion aggregate principal amount of its senior...
-
Nov 23, 2009
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Piper Jaffray Health Care Conference, December 1-2. Ray Elliott,...
-
Nov 20, 2009Complete portfolio of Company's WallFlex Stent family of self-expanding metal stents now available in U.S., Europe and other international markets
Boston Scientific Corporation (NYSE: BSX) today announced that it has received 510(k) clearance from the U.S. Food and Drug...
-
Nov 10, 2009Company supports efforts of International Diabetes Federation to promote worldwide diabetes education and prevention
Boston Scientific Corporation (NYSE: BSX) today announced its official sponsorship of "World Diabetes Day" for the second year in a row. The...
-
Nov 9, 2009
Boston Scientific Corporation (NYSE: BSX) today announced its schedule of events at the 38th annual Global Congress for Minimally Invasive...
-
Nov 9, 2009COGNIS® CRT-D and TELIGEN® ICD are the world's smallest and thinnest high-energy devices
Boston Scientific Corporation (NYSE: BSX) today announced the launch of its COGNIS® cardiac resynchronization therapy defibrillator (CRT-D) and...
-
Nov 6, 2009Company updates third quarter financial results and full-year 2009 guidance
Boston Scientific Corporation (NYSE: BSX) today announced that it has reached an agreement in principle with the U.S. Department of Justice (DOJ)...
-
Nov 2, 2009Third-generation drug-eluting stent now available in CE Mark countries
Boston Scientific Corporation (NYSE: BSX) today announced it has received CE Mark for its PROMUS® Element™ Everolimus-Eluting Coronary Stent...
-
Oct 19, 2009
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the third quarter ended September 30, 2009, as well as guidance for...
-
Oct 9, 2009
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the third quarter ended September 30,...
-
Oct 6, 2009Three models of stenting system now available for palliative treatment of malignant common bile duct strictures
Boston Scientific Corporation (NYSE: BSX) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to...
-
Oct 5, 2009
Boston Scientific Corporation (NYSE: BSX) today announced its exclusive sponsorship and first enrollments of the MADIT-RIT clinical trial. This new...
-
Sep 29, 2009
Boston Scientific Corporation (NYSE: BSX) today announced the settlement of more than a dozen lawsuits involving Johnson & Johnson, including the...
-
Sep 25, 2009
Boston Scientific Corporation (NYSE: BSX) today announced two-year follow-up data from the HORIZONS-AMI trial. The trial,...
-
Sep 23, 2009Results support benefits of paclitaxel-eluting stents in diabetic patients
Boston Scientific Corporation (NYSE: BSX) today welcomed one-year data from the SPIRIT IV clinical trial comparing the XIENCE...
-
Sep 22, 2009Three-year TAXUS ATLAS results show safety and efficacy advantages for Boston Scientific TAXUS Liberte Stent
Boston Scientific Corporation (NYSE: BSX) today announced comprehensive data from the TAXUS ATLAS clinical program, a series of...
-
Sep 21, 2009Both drug-eluting stents performed well in diabetic patients
Boston Scientific Corporation (NYSE: BSX) today welcomed three-year results from the SPIRIT III clinical trial, which continue...
-
Sep 21, 2009
Boston Scientific Corporation (NYSE: BSX) today announced release of its CE-Marked, next-generation iLab System Software for the iLab® Ultrasound...
-
Sep 18, 2009PLATINUM clinical program to support FDA approval of PROMUS® Element™ Stent
Boston Scientific Corporation (NYSE: BSX) today announced the completion of patient enrollment in the workhorse portion of its PLATINUM clinical...
-
Sep 16, 2009
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the Cardiovascular Research...
-
Sep 14, 2009Boston Scientific's Urology/Gynecology Business Forms Marketing Alliance with Bladder Health NetworkAgreement promotes access to testing solutions for female urinary incontinence
Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a co-marketing agreement with Bladder Health Network, a...
-
Sep 10, 2009
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Morgan Stanley Global Healthcare Conference, September 14-15. Ray...
-
Sep 4, 2009
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Thomas Weisel Partners 2009 Health Care Conference, September 9 - 11....
-
Sep 2, 2009
Boston Scientific Corporation (NYSE: BSX) today announced two-year data from its SYNTAX clinical trial comparing percutaneous...
-
Sep 1, 2009
Boston Scientific Corporation (NYSE: BSX) today announced long-term data from the Prevention of Sudden Cardiac Death II registry...
-
Sep 1, 2009Results of landmark heart failure trial published by New England Journal of Medicine and presented at ESC
Boston Scientific Corporation (NYSE: BSX) today announced final results from the landmark MADIT-CRT trial, which were published by the...
-
Aug 31, 2009Dr. Ken Stein to join CRM group
Boston Scientific Corporation (NYSE: BSX) today announced that Ken Stein, M.D., FACC, will join the Company as Senior Vice President and Associate...
-
Aug 27, 2009
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and news announcements for the European...
-
Aug 26, 2009
The statement below is from Pete Nicholas, Chairman of the Board of Boston Scientific Corporation, on behalf of the Company, its employees and its Board of...
-
Aug 24, 2009
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing final results from the landmark MADIT-CRT trial on Tuesday,...
-
Aug 3, 2009
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the BMO Capital Markets 9(th) Annual Focus on Health Care Conference, August 5.
-
Jul 29, 2009
Boston Scientific Corporation (NYSE: BSX) today announced that the Company's Board of Directors has elected Katharine T. Bartlett and Bruce L....
-
Jul 20, 2009
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the second quarter ended June 30, 2009, as well as guidance for net...
-
Jul 16, 2009Longest available drug-eluting stent strengthens Company's broad portfolio
Boston Scientific Corporation (NYSE: BSX) today announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its...
-
Jul 13, 2009
Boston Scientific Corporation (NYSE: BSX) today announced CE Mark for its LATITUDE® Patient Management system. The LATITUDE system remotely...
-
Jul 7, 2009
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the second quarter ended June 30, 2009...
-
Jun 25, 2009
Boston Scientific Corporation (NYSE: BSX) announced today that President and Chief Executive Officer (CEO) Jim Tobin will retire from the Company,...
-
Jun 23, 2009
Landmark trial shows Boston Scientific CRT-Ds slow the progression of heart failure in asymptomatic and mildly symptomatic patients NATICK, Mass., June 23 /PRNewswire-FirstCall/ -- Boston...
-
Jun 18, 2009
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Wachovia 19th Annual Mid-Year Equity Conference, June 23 - 24. Jim...
-
Jun 15, 2009
Boston Scientific Corporation (NYSE: BSX) today announced that results from nine studies involving the Company's Urology/Gynecology products will...
-
May 28, 2009
Studies to be presented on safety and efficacy of SpyGlass System for diagnostic and therapeutic procedures throughout pancreatico-biliary system NATICK, Mass., May 28 /PRNewswire-FirstCall/ --...
-
May 28, 2009
SpyGlass® Direct Visualization System can now be used for diagnostic and therapeutic procedures for pancreatic disease NATICK, Mass., May 28 /PRNewswire-FirstCall/ -- Boston Scientific...
-
May 27, 2009
Boston Scientific Corporation (NYSE: BSX) today announced that Ursula Burns and Kristina Johnson have resigned from the Company's Board of Directors...
-
May 27, 2009
Boston Scientific Corporation (NYSE: BSX) today announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its...
-
May 26, 2009
Risk of death at five years is lower for aneurysm patients treated with coil embolization compared to surgical clipping NATICK, Mass., May 26 /PRNewswire-FirstCall/ -- Boston Scientific...
-
May 20, 2009
Boston Scientific Corporation (NYSE: BSX) today announced the start of patient enrollment in the ORION clinical trial, which is designed to evaluate...
-
May 20, 2009
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of economic and quality of life outcomes,...
-
May 19, 2009
Boston Scientific Corporation (NYSE: BSX) today announced that Fitch Ratings has raised the Company's rating outlook to positive from stable, while...
-
May 19, 2009
Boston Scientific Corporation (NYSE: BSX) today announced positive outcomes from a substudy of patients with left main coronary...
-
May 19, 2009
Boston Scientific Corporation (NYSE: BSX) today announced the launch of the...
-
May 19, 2009
Online tools will help physicians determine treatment strategies NATICK, Mass. and BARCELONA, Spain, May 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today welcomed the...
-
May 15, 2009
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Piper Jaffray PCR Post-Op Summit in London. Jim Tobin, President and...
-
May 15, 2009
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's events and news announcements at the annual EuroPCR...
-
May 14, 2009
Boston Scientific Corporation (NYSE: BSX) today announced data from its ALTITUDE Clinical Science program that show real-word survival rates for...
-
May 14, 2009
Analysis indicates that one life is now saved for every six patients who receive an ICD NATICK, Mass., May 14 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced...
-
May 13, 2009
Boston Scientific Corporation (NYSE: BSX) today announced that it has agreed to donate Cardiac Rhythm Management (CRM) devices, including...
-
May 12, 2009
Company's new lead system reduces implant size of the world's smallest and thinnest high-energy devices NATICK, Mass., May 12 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today...
-
May 11, 2009
Boston Scientific Corporation today welcomed the publication of an article...
-
May 11, 2009
Boston Scientific Corporation today announced the schedule of the Company's major events and news announcements at the 30th Annual Scientific...
-
May 6, 2009
Data from landmark trial provide important insight for physicians in treating heart attack patients NATICK, Mass., May 6 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today welcomed the...
-
May 5, 2009
Boston Scientific Corporation is scheduled to participate in the upcoming Bank of America and Merrill Lynch Health Care Conference. Jim Tobin,...
-
Apr 20, 2009
Boston Scientific Corporation today announced financial results for the first quarter ended March 31, 2009, as well as guidance for net sales and...
-
Apr 15, 2009
Boston Scientific today announced special items that will reduce its GAAP earnings for the first quarter. The Company plans to release its first...
-
Apr 6, 2009
Boston Scientific Corporation will webcast its conference call discussing financial results for the first quarter ended March 31, 2009 on Tuesday,...
-
Mar 31, 2009
Boston Scientific Corporation announced today that the Court of Appeals for the Federal Circuit issued a decision in the Company's stent...
-
Mar 31, 2009
Boston Scientific Corporation today welcomed passage of the National Pain Care Policy Act of 2009 by the U.S. House of Representatives. The...
-
Mar 29, 2009Clinical Data Reinforce Safety and Efficacy of Boston Scientific's Two Drug- Eluting Stent PlatformsThree-year results and two-year pooled analysis presented at ACC demonstrate continued positive outcomes for both PROMUS® and TAXUS® Stents
Boston Scientific Corporation today welcomed three-year results from the SPIRIT II Clinical Trial and a pooled meta-analysis of...
-
Mar 28, 2009
Boston Scientific Corporation today announced results from an analysis of economic and quality of life outcomes, based on...
-
Mar 26, 2009
Boston Scientific Corporation today announced the schedule of the Company's major events and news announcements at the 58th Annual Scientific...
-
Mar 25, 2009
Boston Scientific Corporation today announced that Standard and Poor's Ratings Services has raised the Company's rating outlook to positive from...
-
Mar 19, 2009
Boston Scientific Corporation today announced the launch of its iCross™ Coronary Imaging Catheter, a product designed to improve the...
-
Mar 12, 2009
Boston Scientific Corporation today announced that Moody's Investors Service has raised the Company's rating outlook to stable from negative. In...
-
Mar 10, 2009
Boston Scientific Corporation is scheduled to participate in the upcoming Cowen and Company 29th Annual Health Care Conference. Jim Tobin, Chief...
-
Mar 4, 2009
Boston Scientific Corporation today welcomed approval by the U.S. House of Representative's Energy and Commerce Committee of the National Pain Care...
-
Mar 3, 2009
Boston Scientific Corporation today announced the launch of its TAXUS®...
-
Mar 2, 2009
Boston Scientific Corporation today announced that the Company's Board of Directors has elected John E. Sununu...
-
Feb 26, 2009
Boston Scientific Corporation today announced updated financial results for the fourth quarter ended December 31, 2008. Subsequent to the release...
-
Feb 18, 2009
Data show comparable safety for complex patients treated with TAXUS® Express2™ Stents and bypass surgery NATICK, Mass., Feb. 18 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today...
-
Feb 5, 2009
Journal of American College of Cardiology publishes positive ATLAS clinical data NATICK, Mass., Feb. 5 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced that it has submitted...
-
Feb 3, 2009
PLATINUM clinical program to evaluate PROMUS™ Element™ Platinum Chromium Stent NATICK, Mass., Feb. 3 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced the beginning of...